- Home
- ORIC vs VZLA Comparison
ORIC vs VZLA Comparison
Compare ORIC & VZLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORIC | VZLA |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ORIC | VZLA |
|---|---|---|
| Price | $12.55 | $3.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $21.08 | N/A |
| AVG Volume (30 Days) | 1.2M | ★ 4.0M |
| Earning Date | 11-12-2026 | 09-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 19.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.23 | $2.88 |
| 52 Week High | $14.93 | $7.19 |
Technical Indicators
Market Signals| Indicator | ORIC | VZLA |
|---|---|---|
| Relative Strength Index (RSI) | 57.13 | 46.43 |
| Support Level | $13.12 | $3.52 |
| Resistance Level | $14.22 | $3.95 |
| Average True Range (ATR) | 0.69 | 0.16 |
| MACD | 0.06 | -0.04 |
| Stochastic Oscillator | 73.36 | 30.56 |
Price Performance
Historical ComparisonAbout ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About VZLA Vizsla Silver Corp.
Vizsla Silver Corp is the exploration of mineral properties. The company currently conducts substantially all its operations in Canada and Mexico in one reportable segment. The company has one reportable segment, mainly mineral exploration, evaluation and development. Its project includes Panuco Project.